Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Unstable angina in 1998.

P R Lichtlen

    Thrombosis and Haemostasis
    |March 1, 2000
    PubMed
    Summary
    This summary is machine-generated.

    Unstable angina and non-Q-wave myocardial infarction involve temporary coronary artery blockages. Treatment focuses on preventing heart attacks using vasodilators, antiplatelet drugs, and anticoagulants.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    History of coronary heart disease.

    Zeitschrift fur Kardiologie·2002
    Same author

    Analysis of arrhythmias in the Circadian Antiischemia Program in Europe (CAPE) study.

    Journal of cardiovascular pharmacology·1999
    Same author

    Comparison of ECG variables of dispersion of ventricular repolarization with direct myocardial repolarization measurements in the human heart.

    Journal of cardiovascular electrophysiology·1998
    Same author

    [Ambulatory coronary angiography and PTCA].

    Herz·1998
    Same author

    Sixty-minute alteplase protocol: a new accelerated recombinant tissue-type plasminogen activator regimen for thrombolysis in acute myocardial infarction.

    Journal of the American College of Cardiology·1997
    Same author

    Assessment of myocardial viability by use of 11C-acetate and positron emission tomography. Threshold criteria of reversible dysfunction.

    Circulation·1997
    Same journal

    Discontinuation of Oral Anticoagulation After Successful Catheter Ablation for Atrial Fibrillation: Meta-analysis of Randomized Clinical Trials.

    Thrombosis and haemostasis·2026
    Same journal

    Novel/Recurrent Variants in Pakistani Glanzmann Thrombasthenia and Glanzmann-like bleeding diathesis: Insights from NGS Analysis.

    Thrombosis and haemostasis·2026
    Same journal

    Anti-TFPI Single-Domain Antibodies: Novel Rebalancing Therapies for Hemophilia and Other Rare Bleeding Disorders.

    Thrombosis and haemostasis·2026
    Same journal

    The Interaction of Fibrin with Endothelial Cell Receptor N-Cadherin Promotes Fibrin-Dependent Angiogenesis.

    Thrombosis and haemostasis·2026
    Same journal

    Antiphospholipid Antibodies and Atrial Fibrillation: Clinical Implications and the TaPL AF Study Design.

    Thrombosis and haemostasis·2026
    Same journal

    Prasugrel vs. Ticagrelor: Can TUXEDO-2 Settle the Debate?

    Thrombosis and haemostasis·2026
    See all related articles

    Area of Science:

    • Cardiology
    • Vascular Medicine

    Background:

    • Unstable angina (UA) and non-Q-wave myocardial infarction (NQWMI) are acute coronary syndromes characterized by transient ischemic events.
    • These conditions stem from reduced coronary blood flow and reversible arterial lumen narrowing, often involving thrombus formation and vasoconstriction.
    • The short duration of ischemic episodes typically results in minimal to no irreversible myocardial damage.

    Purpose of the Study:

    • To outline the pathophysiology of unstable angina and non-Q-wave myocardial infarction.
    • To describe the primary treatment goals for these acute coronary syndromes.
    • To detail the pharmacological and interventional strategies employed to manage these conditions.

    Main Methods:

    • Review of the underlying mechanisms of acute coronary syndromes.

    Related Experiment Videos

  • Description of therapeutic interventions including vasodilators, antiplatelet agents, and anticoagulants.
  • Discussion of diagnostic procedures and revascularization options such as coronary angiography, PTCA, and CABG.

    • Main Results:

    • Effective management can prevent the progression of UA and NQWMI to myocardial infarction in most cases.
    • Pharmacological treatments like nitrates, amlodipine, beta-blockers, heparin, and GPIIb/IIIa inhibitors are crucial.
    • Interventional procedures like PTCA or CABG may be necessary for advanced cases.

    Conclusions:

    • Prompt and adequate treatment is essential for stabilizing acute coronary syndromes.
    • A combination of medical therapy and potential revascularization strategies can effectively manage UA and NQWMI.
    • These interventions aim to prevent further ischemic events and allow for subsequent diagnostic and therapeutic planning.